Cargando…
The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance
Autores principales: | Zhang, Chaoqi, Zhang, Zhihui, Zhang, Zhen, Luo, Yuejun, Wu, Peng, Zhang, Guochao, Xue, Liyan, Zeng, Qingpeng, Wang, Lide, Yang, Zhaoyang, Zeng, Hua, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Sun, Nan, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474928/ https://www.ncbi.nlm.nih.gov/pubmed/34579719 http://dx.doi.org/10.1186/s12943-021-01408-5 |
Ejemplares similares
-
Comprehensive analyses of N
(6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
por: Luo, Yuejun, et al.
Publicado: (2022) -
m(6)A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021) -
Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021) -
An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021) -
Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)